Taipei Veterans General Hospital Introduces Histotripsy Ultrasound Technology, Adding a New Weapon to Liver Cancer Treatment
Taipei Veterans General Hospital (TVGH) has introduced the non-invasive tumor treatment technology "Histotripsy Ultrasound" as a new option for liver cancer treatment, thanks to funding from a public welfare trust. This makes TVGH the only medical center worldwide to simultaneously possess three major cancer treatment modalities: heavy particle therapy, boron neutron capture therapy, and histotripsy ultrasound.
📋 Article Processing Timeline
- 📰 Published: May 11, 2026 at 20:01
- 🔍 Collected: May 11, 2026 at 20:32 (30 min after Published)
- 🤖 AI Analyzed: May 11, 2026 at 21:52 (1h 20m after Collected)
Central News Agency
(Central News Agency reporter Tseng Yi-Ning, Taipei 11th) Taipei Veterans General Hospital (TVGH) has introduced the non-invasive tumor treatment technology "Histotripsy Ultrasound" as a new option for liver cancer treatment, thanks to funding from a public welfare trust. The hospital has become the only medical center to simultaneously possess three major weapons: heavy particle therapy, boron neutron capture therapy, and histotripsy ultrasound.
Taipei Veterans General Hospital held a donation ceremony today, expressing gratitude for the funding from the Lin Yu-Lin Hongtai Public Welfare Trust, and signed a memorandum of understanding with the Lin Yu-Lin Hongtai Education Foundation, declaring their joint commitment to promoting the clinical application of "Histotripsy" technology and moving towards establishing an "Asia-Pacific Histotripsy Non-Invasive Treatment Observation and Demonstration Center."
TVGH Superintendent Chen Wei-Ming stated in his speech that over one-third of TVGH's inpatients are cancer patients. If cancer treatment tools are likened to weapons in wuxia novels, heavy particles are like the "Xuan Tie Heavy Sword," boron neutrons are the "Dragon Slaying Saber," and histotripsy ultrasound is the "Heavenly Sword." With this donation, TVGH will become the only medical center in the world to possess these three weapons.
Chen Wei-Ming said that these three weapons each have their strengths. Heavy particle therapy has accumulated 730 cases, including over 200 cases of pancreatic cancer, witnessing countless miracles; the boron neutron accelerator has recently been installed and is expected to be operational as early as next year; histotripsy ultrasound can treat liver cancer and is expected to be applied to various other cancers such as pancreatic cancer, prostate cancer, and breast cancer in the future, offering more treatment options.
Huang Yi-Hsiang, Director of the TVGH Medical Research Department and Chairman of the Taiwan Liver Cancer Society, pointed out that histotripsy ultrasound is a revolutionary "non-thermal" ablation technology. Traditional thermal ablation technology uses high temperatures to destroy tumor tissue but requires piercing into the human body and carries the risk of damaging adjacent blood vessels or bile ducts.
Huang Yi-Hsiang explained that histotripsy technology uses the cavitation effect generated by high-intensity focused ultrasound, like "miniature bombs," to precisely destroy tumor tissue without causing thermal damage or any wounds. This effectively preserves surrounding critical structures, making it particularly suitable for treating tumors in challenging locations; in addition to liver cancer, other body cancers are also actively being developed for this application.
Huang Yi-Hsiang pointed out that a key clinical trial data from 2024 showed that among 44 patients with liver cancer and liver metastases who participated in histotripsy ultrasound treatment, 95.5% showed tumor shrinkage on imaging after the procedure, and the incidence of major complications was only 7%, with other common complications being pain at the treatment site.
TVGH Vice Superintendent Hou Ming-Chih pointed out that histotripsy ultrasound is valued at over NT$100 million, and TVGH also received 50 sets of consumables. Clinical trials will be conducted for patients with liver cancer and liver metastases, with patient enrollment expected to be completed in about half a year, after which trials for other cancer types can begin. (Editor: Chen Ching-Fang) 1150511
Choose to stand with facts, every sponsorship you make is a force to protect press freedom.
Download the Central News Agency "First-hand News" APP to stay updated with the latest news.
The text, images, and videos on this website may not be reproduced, publicly broadcast, publicly transmitted, or utilized without authorization.
(Central News Agency reporter Tseng Yi-Ning, Taipei 11th) Taipei Veterans General Hospital (TVGH) has introduced the non-invasive tumor treatment technology "Histotripsy Ultrasound" as a new option for liver cancer treatment, thanks to funding from a public welfare trust. The hospital has become the only medical center to simultaneously possess three major weapons: heavy particle therapy, boron neutron capture therapy, and histotripsy ultrasound.
Taipei Veterans General Hospital held a donation ceremony today, expressing gratitude for the funding from the Lin Yu-Lin Hongtai Public Welfare Trust, and signed a memorandum of understanding with the Lin Yu-Lin Hongtai Education Foundation, declaring their joint commitment to promoting the clinical application of "Histotripsy" technology and moving towards establishing an "Asia-Pacific Histotripsy Non-Invasive Treatment Observation and Demonstration Center."
TVGH Superintendent Chen Wei-Ming stated in his speech that over one-third of TVGH's inpatients are cancer patients. If cancer treatment tools are likened to weapons in wuxia novels, heavy particles are like the "Xuan Tie Heavy Sword," boron neutrons are the "Dragon Slaying Saber," and histotripsy ultrasound is the "Heavenly Sword." With this donation, TVGH will become the only medical center in the world to possess these three weapons.
Chen Wei-Ming said that these three weapons each have their strengths. Heavy particle therapy has accumulated 730 cases, including over 200 cases of pancreatic cancer, witnessing countless miracles; the boron neutron accelerator has recently been installed and is expected to be operational as early as next year; histotripsy ultrasound can treat liver cancer and is expected to be applied to various other cancers such as pancreatic cancer, prostate cancer, and breast cancer in the future, offering more treatment options.
Huang Yi-Hsiang, Director of the TVGH Medical Research Department and Chairman of the Taiwan Liver Cancer Society, pointed out that histotripsy ultrasound is a revolutionary "non-thermal" ablation technology. Traditional thermal ablation technology uses high temperatures to destroy tumor tissue but requires piercing into the human body and carries the risk of damaging adjacent blood vessels or bile ducts.
Huang Yi-Hsiang explained that histotripsy technology uses the cavitation effect generated by high-intensity focused ultrasound, like "miniature bombs," to precisely destroy tumor tissue without causing thermal damage or any wounds. This effectively preserves surrounding critical structures, making it particularly suitable for treating tumors in challenging locations; in addition to liver cancer, other body cancers are also actively being developed for this application.
Huang Yi-Hsiang pointed out that a key clinical trial data from 2024 showed that among 44 patients with liver cancer and liver metastases who participated in histotripsy ultrasound treatment, 95.5% showed tumor shrinkage on imaging after the procedure, and the incidence of major complications was only 7%, with other common complications being pain at the treatment site.
TVGH Vice Superintendent Hou Ming-Chih pointed out that histotripsy ultrasound is valued at over NT$100 million, and TVGH also received 50 sets of consumables. Clinical trials will be conducted for patients with liver cancer and liver metastases, with patient enrollment expected to be completed in about half a year, after which trials for other cancer types can begin. (Editor: Chen Ching-Fang) 1150511
Choose to stand with facts, every sponsorship you make is a force to protect press freedom.
Download the Central News Agency "First-hand News" APP to stay updated with the latest news.
The text, images, and videos on this website may not be reproduced, publicly broadcast, publicly transmitted, or utilized without authorization.